Cooperative Agreement U01AG097744
Award Date 9/23/25
Completion Date 8/31/30
Dollars Obligated $450K
Federal Agency
Federal Grant Program
Assistance Type
Cooperative Agreement
Place of Performance
Kenya
Similar Awards
- The National Institutes of Health (NIH) National Institute on Aging awarded a $2,721,062 project grant under the Aging Research program (CFDA 93.866) to the University of Michigan for the Longitudinal Study of Health and Ageing in Kenya (LOSHAK). The study aims to generate population-level data on health, economics, wellbeing, and Alzheimer's disease/related dementias among older Kenyan adults. Wave 1 data collection for the nationally representative LOSHAK-Core study (n=6,580 aged 45+) and...
- The National Institute on Aging (NIA) awarded a $558,193 Cooperative Agreement under the Aging Research Federal Grant Program (CFDA 93.866) to The Regents of the University of California, San Francisco (UCSF) for the "Bridging Research Infrastructure for Dementia Gaps in East Africa (BRIDGE-AFRICA)" project. The funding will be used to build research infrastructure for Alzheimer's disease and related dementias (ADRD) in East Africa, building on UCSF's existing expertise and...
- This federal Cooperative Agreement award for $455,035 was granted on August 15, 2025 by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866). The award, titled "Leading Equitable Research in Alzheimer's Disease in Africa (LEAD Africa)," aims to establish an Alzheimer's disease and related dementias (AD/ADRD) research infrastructure in resource-limited areas of Africa. The project will be executed through a collaboration between research...
- This federal Project Grant award of $223,813 from the National Institute on Aging (CFDA 93.866 Aging Research) supports a 2-year cross-sectional and longitudinal study in Nigeria to investigate the use of plasma biomarkers, social determinants of health, and lifestyle factors in classifying and predicting mild cognitive impairment and Alzheimer's disease. The study will enroll 264 participants across three cognitive status groups (Alzheimer's disease, mild cognitive impairment, and healthy...
- This Cooperative Agreement award from the National Institute on Aging (CFDA 93.866 Aging Research) provides $536,527 to the University of Miami to establish the Global Alzheimer's and Dementia Partnership to Advance Neuroscience in LMICs (GAP-ADN) Coordinating Center. The key objectives are to coordinate consortium activities, promote collaboration across the Alzheimer's and dementia research community, facilitate training opportunities, and coordinate data sharing to integrate research progress...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $108,000 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Kenyatta National Hospital (KNH) in Kenya. The purpose of this 2-year grant, with an award date of August 1, 2024 and a completion date of January 31, 2026, is to strengthen KNH's pre-award grants management capacity. The key products and services to be delivered through this funding include: 1) Training two senior research...
- This Cooperative Agreement award from the National Institute on Aging (part of the U.S. Department of Health and Human Services), under the Aging Research Federal Grant Program (CFDA 93.866), will provide $539,352 to incorporate portable, low-field brain MRI into a population-representative study of Alzheimer's disease and related dementias in rural South Africa. The project, led by The Trustees of Columbia University in the City of New York, aims to transform the ability to assess brain atrophy...
- The College of Medicine, University of Ibadan was awarded a $487,582 Cooperative Agreement on September 19, 2025 by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866). The goal of the project, titled "Cerebral Small Vessel Disease and Brain Health in an Indigenous African Cohort (CSVD-IAC)", is to characterize the burden of cerebral small vessel disease in a population-based cohort of older Nigerians. The project will recruit an...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports a $163,080 research project titled "Bridging Gaps to Translate Plasma Alzheimer's Disease Biomarkers to Diverse Populations." The project, led by the University of Texas Health Science Center at San Antonio, aims to address critical gaps in understanding the performance of plasma biomarkers for Alzheimer's disease and related dementias in diverse population cohorts, including in the...
- This Cooperative Agreement award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $7,417,428 to Brigham & Women's Hospital, a subsidiary of the Partners Healthcare System, to develop a toolkit of 2D and 3D microphysiological systems (MPS) that capture human genetic diversity underlying risk and resilience to Alzheimer's disease (AD) and related dementias (ADRD). The award period is from July 1, 2025 to June 30, 2030. The project aims to leverage iPSC lines from...